| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.007 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |